Login to Your Account

Financings NEWS

CEO Donald McCaffrey told BioWorld that Resverlogix Corp.'s unpaid loan of $68.8 million is "something we don't want, and our shareholders don't want it, and we are very pleased to have that circumstance on the way out."

Spruce Biosciences Inc. landed a $20 million series A last year but kept the financing under wraps, waiting for its only asset, SPR-001, to achieve its first clinical milestone.

DUBLIN – Virionhealth Ltd., a newly funded U.K. startup, raised up to £13 million in series A funding to take forward a novel approach for preventing and treating respiratory viral infections, which relies on a long-recognized quirk of viral replication that has long been overlooked by the biotechnology industry.

More Financings Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: